Stock of the Day

March 2, 2020

West Pharmaceutical Services (WST)

$358.77
-$3.67 (-1.0%)
Market Cap: $25.61B

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services Bull Case

Here are some ways that investors could benefit from investing in West Pharmaceutical Services, Inc.:

  • The current stock price is around $320, reflecting a strong market position and investor confidence in the company's growth potential.
  • West Pharmaceutical Services, Inc. reported a significant year-over-year revenue increase of 21.0%, indicating robust demand for its products and services in the pharmaceutical and biotech sectors.
  • The company has a solid return on equity of 19.03%, showcasing its ability to generate profits from shareholders' equity, which is a positive indicator for potential investors.
  • With a low debt-to-equity ratio of 0.07, West Pharmaceutical Services, Inc. demonstrates strong financial stability and a conservative approach to leveraging, reducing risk for investors.
  • The firm has set ambitious earnings guidance for FY 2026, projecting EPS between 8.400 and 8.750, which suggests confidence in continued profitability and growth.

West Pharmaceutical Services Bear Case

Investors should be bearish about investing in West Pharmaceutical Services, Inc. for these reasons:

  • The stock has a relatively high PE ratio of 44.93, which may indicate that it is overvalued compared to its earnings, potentially leading to a price correction.
  • Despite strong revenue growth, the price-to-earnings-growth (P/E/G) ratio of 2.76 suggests that the stock may not be a bargain, as it reflects a higher valuation relative to its growth rate.
  • The beta of 1.18 indicates that the stock is more volatile than the market, which could lead to greater risk for investors during market fluctuations.
  • With a current ratio of 2.71, while it shows good short-term financial health, it may also indicate that the company is not efficiently using its assets to generate revenue.
  • Recent earnings results, while positive, may not be sustainable in the long term, raising concerns about future performance and market expectations.
← Previous Stock of the DayNext Stock of the Day →

Recent News